68Ga-PSMA PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy in Patients With Elevated PSA
Phase of Trial: Phase II
Latest Information Update: 16 May 2017
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 09 May 2017 Status changed from not yet recruiting to recruiting.
- 13 Apr 2017 Planned number of patients changed from 200 to 60.
- 13 Apr 2017 Planned End Date changed from 1 Jun 2021 to 1 Aug 2021.